1GA
EW icon

1st Global Advisors’s Edwards Lifesciences EW Stock Holding History

1st Global Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,432
Closed -$295K – 516
2016
Q4 		$295K Sell
9,432
-2,982
-24% -$96.6K 0.04% 382
2016
Q3 		$499K Buy
+12,414
New +$468K 0.07% 256

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

1st Global Advisors's EW Position: Q1 2017 in Review

1st Global Advisors sold out of Edwards Lifesciences (EW) in Q1 2017, closing a stake of 9,432 shares — an estimated $295K sold.

1st Global Advisors first reported a position in EW in Q3 2016 and held it in 2 quarters. The position peaked at $499K in Q3 2016. 690 funds tracked by Wall St. Rank hold EW as of Q1 2017.

  • 1st Global Advisors reported no remaining Edwards Lifesciences position as of Q1 2017 after selling out during the quarter.
  • 1st Global Advisors sold 9,432 Edwards Lifesciences shares in Q1 2017, an estimated $295K.
  • 1st Global Advisors first reported a position in Edwards Lifesciences in Q3 2016 and held it in 2 quarters.
  • 1st Global Advisors's Edwards Lifesciences position peaked at $499K in Q3 2016.
  • 690 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on 1st Global Advisors's 13F filing for Q1 2017, filed 9 May 2017.